DOCT FIRST TR EXCHNG TRADED FD VI

Ownership history in UBS Group AG  ·  14 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in FIRST TR EXCHNG TRADED FD VI (DOCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 1,033 -3,723 -78.3% 0.00% $45K $43.20
2025 Q1 ADDED 4,756 +4,378 +1158.2% 0.00% $182K $38.35
2024 Q4 REDUCED 378 -3,964 -91.3% 0.00% $15K $39.37
2024 Q3 ADDED 4,342 +2,557 +143.2% 0.00% $169K $39.03
2024 Q2 ADDED 1,785 +666 +59.5% 0.00% $69K $38.39
2024 Q1 REDUCED 1,119 -4,045 -78.3% 0.00% $42K $37.62
2023 Q2 ADDED 5,164 +1,214 +30.7% 0.00% $180K $34.90
2023 Q1 ADDED 3,950 +1,308 +49.5% 0.00% $130K $32.83
2022 Q4 ADDED 2,642 +2,544 +2595.9% 0.00% $83K $31.31
2022 Q1 REDUCED 98 -1,353 -93.2% 0.00% $3K $32.69
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DOCT price (monthly, adj. close)
← Back to UBS Group AG Holdings